<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36276994</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1748-6718</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Computational and mathematical methods in medicine</Title><ISOAbbreviation>Comput Math Methods Med</ISOAbbreviation></Journal><ArticleTitle>Study on the Diagnostic Value of Neuroelectrophysiological Examination in Patients with Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>3907751</StartPage><MedlinePgn>3907751</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3907751</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2022/3907751</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with unknown causes involving upper and lower motor neurons. Our study aimed to explore the diagnostic value of neuroelectrophysiological examination in patients with amyotrophic lateral sclerosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 64 patients admitted to our hospital from January 2014 to December 2020 were selected as ALS group. Additionally, 64 normal healthy people in the same period were selected as the control group. Electrophysiological tests were performed on all personnel involved in the study, and the results and parameter changes of different personnel were compared and analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">There was a statistical difference between the EMG data of clinically confirmed ALS and the proposed ALS and possible ALS (<i>p</i> &lt; 0.05). The abnormality of confirmed ALS was particularly obvious, and the overall abnormal rate of EMG in ALS was 85%. The CMCT of the upper and lower limbs of clinically diagnosed ALS, suspected ALS, and possible ALS were longer than that of the normal group (<i>p</i> &lt; 0.05). There was no significant statistical difference between clinically diagnosed ALS and suspected ALS (<i>p</i> &gt; 0.05), and there was a difference between clinically diagnosed ALS and possible ALS (<i>p</i> &lt; 0.05). In ALS group, the frequency of F wave decreased, which may be related to the involvement of F wave conduction pathway and the degree of lower motor neuron involvement (<i>p</i> &lt; 0.05). In addition, the amplitudes of F and H waves increased, which was related to the involvement of upper motor neurons (<i>p</i> &lt; 0.05). In ALS group, SCV was hardly involved, and CMAP decreased significantly, which was positively correlated with the degree of muscular atrophy and muscle strength decline (<i>p</i> &lt; 0.05). The sensitivity of electrophysiological detection was 76.56%, the specificity was 78.33%, and the AUC was 0.8578.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Patients with clinically suspected ALS should undergo electrophysiological testing as soon as possible, which is conducive to the early diagnosis and differential diagnosis of ALS. This trial is registered with ChiCTR2100046535.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Guiyun Ding and Yahua Fan.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Guiyun</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7277-4978</Identifier><AffiliationInfo><Affiliation>Department of EMG Laboratory, Nanping First Hospital Affiliated to Fujian Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yahua</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jian'ou Municipal Hospital of Fujian Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Math Methods Med</MedlineTA><NlmUniqueID>101277751</NlmUniqueID><ISSNLinking>1748-670X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors confirm that there are no conflicts of interest in this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>24</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36276994</ArticleId><ArticleId IdType="pmc">PMC9581655</ArticleId><ArticleId IdType="doi">10.1155/2022/3907751</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Foster L. A., Salajegheh M. K. Motor neuron disease: pathophysiology, diagnosis, and management. The American Journal of Medicine . 2019;132(1):32&#x2013;37. doi: 10.1016/j.amjmed.2018.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2018.07.012</ArticleId><ArticleId IdType="pubmed">30075105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M. C., Vucic S., Cheah B. C., et al. Amyotrophic lateral sclerosis. The Lancet . 2011;377(9769):942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R. H., Al-Chalabi A. Amyotrophic lateral sclerosis. The New England Journal of Medicine . 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., al-Chalabi A., Chio A., et al. Amyotrophic lateral sclerosis. Nature Reviews Disease Primers . 2017;3(1, article 17071) doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Govaarts R., Beeldman E., Kampelmacher M. J., et al. The frontotemporal syndrome of ALS is associated with poor survival. Journal of Neurology . 2016;263(12):2476&#x2013;2483. doi: 10.1007/s00415-016-8290-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8290-1</ArticleId><ArticleId IdType="pmc">PMC5110703</ArticleId><ArticleId IdType="pubmed">27671483</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L. L., Yin H. X., Liu M. S., Cui L. Y. Study on variation trend of repetitive nerve stimulation waveform in amyotrophic lateral sclerosis. Chinese Medical Journal . 2019;132(5):542&#x2013;550. doi: 10.1097/CM9.0000000000000117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000117</ArticleId><ArticleId IdType="pmc">PMC6415996</ArticleId><ArticleId IdType="pubmed">30807353</ArticleId></ArticleIdList></Reference><Reference><Citation>Karvelas K., Ziegler C., Rho M. E. Resident accuracy of electromyography needle electrode placement using ultrasound verification. PM &amp; R : The Journal of Injury, Function, and Rehabilitation . 2016;8(8):748&#x2013;753. doi: 10.1016/j.pmrj.2015.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmrj.2015.11.011</ArticleId><ArticleId IdType="pmc">PMC4983541</ArticleId><ArticleId IdType="pubmed">26690019</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;t&#x11b;tk&#xe1;&#x159;ov&#xe1; I., Ehler E. Diagnostics of amyotrophic lateral sclerosis: up to date. Diagnostics (Basel) . 2021;11(2) doi: 10.3390/diagnostics11020231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11020231</ArticleId><ArticleId IdType="pmc">PMC7913557</ArticleId><ArticleId IdType="pubmed">33546386</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Asseldonk J. T. H., Franssen H., Van den Berg-Vos R. M., Wokke J. H., Van den Berg L. H. Multifocal motor neuropathy. The Lancet Neurology . 2005;4(5):309&#x2013;319. doi: 10.1016/S1474-4422(05)70074-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70074-0</ArticleId><ArticleId IdType="pubmed">15847844</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowacek D. G., Teener J. W. Multifocal motor neuropathy. Seminars in Neurology . 2012;32(5):500&#x2013;505. doi: 10.1055/s-0033-1334468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1334468</ArticleId><ArticleId IdType="pubmed">23677657</ArticleId></ArticleIdList></Reference><Reference><Citation>Breza M., Koutsis G. Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease. Journal of Neurology . 2019;266(3):565&#x2013;573. doi: 10.1007/s00415-018-8968-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8968-7</ArticleId><ArticleId IdType="pubmed">30006721</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R., Sorar&#xfa; G., Grunseich C., et al. Beyond motor neurons: expanding the clinical spectrum in Kennedy's disease. Journal of Neurology, Neurosurgery, and Psychiatry . 2018;89(8):808&#x2013;812. doi: 10.1136/jnnp-2017-316961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316961</ArticleId><ArticleId IdType="pmc">PMC6204939</ArticleId><ArticleId IdType="pubmed">29353237</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukahara A., Hosokawa T., Nishioka D., et al. Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathy. Scientific Reports . 2021;11(1, article 22827) doi: 10.1038/s41598-021-02310-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02310-2</ArticleId><ArticleId IdType="pmc">PMC8613178</ArticleId><ArticleId IdType="pubmed">34819571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamoei S., Hvid L. G., Boye Jensen H., Zijdewind I., Stenager E., Dalgas U. Neurophysiological impairments in multiple sclerosis-central and peripheral motor pathways. Acta Neurologica Scandinavica . 2020;142(5):401&#x2013;417. doi: 10.1111/ane.13289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13289</ArticleId><ArticleId IdType="pubmed">32474916</ArticleId></ArticleIdList></Reference><Reference><Citation>Duclos Y., Grapperon A. M., Jouve E., et al. Motor-evoked potential gain is a helpful test for the detection of corticospinal tract dysfunction in amyotrophic lateral sclerosis. Clinical Neurophysiology . 2017;128(2):357&#x2013;364. doi: 10.1016/j.clinph.2016.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.12.015</ArticleId><ArticleId IdType="pubmed">28068522</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang B., Qian Z., Wang Z., et al. Fluctuation of primary motor cortex excitability during cataplexy in narcolepsy. Annals of Clinical Translational Neurology . 2019;6(2):210&#x2013;221. doi: 10.1002/acn3.670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.670</ArticleId><ArticleId IdType="pmc">PMC6389735</ArticleId><ArticleId IdType="pubmed">30847354</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;sler K. M., Truffert A., Hess C. W., Magistris M. R. Quantification of upper motor neuron loss in amyotrophic lateral sclerosis. Clinical Neurophysiology . 2000;111(12):2208&#x2013;2218. doi: 10.1016/S1388-2457(00)00481-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-2457(00)00481-8</ArticleId><ArticleId IdType="pubmed">11090774</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson E. J. The electrophysiology of the motor neuron diseases. Neurologic Clinics . 2012;30(2):605&#x2013;620. doi: 10.1016/j.ncl.2011.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2011.12.006</ArticleId><ArticleId IdType="pubmed">22361376</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Jiang J. Y., Lu F. Z., Xia X. L., Wang L. X., Zheng C. J. Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy. BMC Musculoskeletal Disorders . 2014;15(1):p. 349. doi: 10.1186/1471-2474-15-349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-15-349</ArticleId><ArticleId IdType="pmc">PMC4216382</ArticleId><ArticleId IdType="pubmed">25319248</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J., Cui L. Y., Liu M. S., et al. F wave study in amyotrophic lateral sclerosis: assessment of segmental motoneuronal dysfunction. Chinese Medical Journal . 2015;128(13):1738&#x2013;1742. doi: 10.4103/0366-6999.159346.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.159346</ArticleId><ArticleId IdType="pmc">PMC4733717</ArticleId><ArticleId IdType="pubmed">26112713</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeil C. J., Butler J. E., Taylor J. L., Gandevia S. C. Testing the excitability of human motoneurons. Frontiers in Human Neuroscience . 2013;7:p. 152. doi: 10.3389/fnhum.2013.0015.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2013.0015</ArticleId><ArticleId IdType="pmc">PMC3633937</ArticleId><ArticleId IdType="pubmed">23630483</ArticleId></ArticleIdList></Reference><Reference><Citation>Veltsista D., Papapavlou C., Chroni E. F wave analyzer, a system for repeater F-waves detection: application in patients with amyotrophic lateral sclerosis. Clinical Neurophysiology . 2019;130(10):1954&#x2013;1961. doi: 10.1016/j.clinph.2019.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2019.08.002</ArticleId><ArticleId IdType="pubmed">31472478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z. L., Liu M., Ding Q., Hu Y., Cui L. Split-hand index in amyotrophic lateral sclerosis: an F-wave study. Amyotroph Lateral Scler Frontotemporal Degener . 2019;20(7-8):562&#x2013;567. doi: 10.1080/21678421.2019.1646770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1646770</ArticleId><ArticleId IdType="pubmed">31364874</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>